Clarification
This article was originally published in The Gray Sheet
Executive Summary
A story in the Feb. 2 issue of "The Gray Sheet" (1p. 8) mentions NuVasive, TranS1 and Alphatec Spine as examples of spine device manufacturers. The story does not intend to suggest that the firms are under investigation by the government
You may also be interested in...
Spine Society Adopts Stricter Conflict Disclosure Policy
Members of the North American Spine Society and all practitioners who present at NASS meetings, publish in its journals, or serve on its committees will for the first time need to disclose dollar amounts of financial ties to device companies
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.